A federal study with support from Duluth researchers has tracked the first two COVID-19 vaccines approved in the U.S. and found that they were 90% effective in real-world conditions and prevented asymptomatic infections.
Clinical trials of the Moderna and Pfizer vaccines looked only at prevention of symptomatic infections, so the latest study of their effectiveness in health care and emergency medical workers is a significant advance, said Dr. Harmony Tyner, an infectious disease specialist at St. Luke's Regional Health Care System in Duluth.
"It protects against asymptomatic infections as well," said Tyner, a co-author of the study published Monday by the U.S. Centers for Disease Control and Prevention. "We know it kept people alive, we know it kept people from dying, but [the clinical trials] didn't test against asymptomatic infections, which is huge."
The finding is a boost for aggressive vaccination as a key response to the pandemic in Minnesota, where there have been 6,835 COVID-19 deaths and 516,608 diagnosed infections with the novel coronavirus that causes the disease. The totals include five deaths and 1,550 infections reported on Monday amid continued signs of a new COVID-19 wave in Minnesota.
The state on Monday reported that 1,609,277 people have received a first dose of COVID-19 vaccine and 990,854 have completed the series either by receiving two Moderna and Pfizer shots or a single-dose of Johnson & Johnson vaccine.
All Minnesotans 16 and older will technically be eligible Tuesday to receive vaccine, but quantities remain limited and many medical providers are continuing to reserve doses for those at greatest risk of viral exposure or severe COVID-19 illness.
Gov. Tim Walz and former Gov. Tim Pawlenty are publicly receiving J&J vaccine shots on Tuesday.
The state reported that 81% of senior citizens and at least 66% of K-12 and child-care educators have received vaccine. They were initial priority groups in Minnesota along with long-term care residents, health care workers and non-elderly adults with qualifying medical conditions or front-line occupations.